Hold off on inoculating people ages 60 and older against chikungunya infection with the Ixchiq vaccine, the FDA and CDC ...

The Trump administration's FDA and CDC is advising U.S. patients using the drug Ixchiq to hold off while U.S. health ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

The United States is advising travellers aged 60 and up to hold off on getting the chikungunya vaccine while it looks into reports of possible side effects.

The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a ...

Key Takeaways U.S. health agencies are investigating possible side effects of a chikungunya vaccineOlder adults, especially ...

The soaring popularity of smartphone apps that scan barcodes on food products to provide health scores are empowering ...

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

The US Centers for Disease Control and Prevention (CDC) is warning people planning to travel to the Region of the Indian ...

Federal health officials are advising Americans aged 60 and older to avoid the chikungunya vaccine Ixchiq amid an ...

The FDA and CDC recommended the pause while the government looks into possible side effects. Also: RFK Jr. raises eyebrows after swimming with his grandkids in a contaminated creek; President Donald ...